Viewing Study NCT00387933


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2025-12-26 @ 1:32 AM
Study NCT ID: NCT00387933
Status: COMPLETED
Last Update Posted: 2015-10-14
First Post: 2006-10-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
Sponsor: Duke University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module